BioSpace News Archive

The Lupus Research Alliance (LRA) is pleased to announce the reimagination of its highly successful, multi-city program with a virtual ManyOne Can Walk with Us to Cure Lupus celebratory Walk experience. The aim is to unite and inspire the entire lupus community on one day, Saturday, September 12, 2020 -- to achieve one goal: raise

Scientists from ExxonMobil, University of California, Berkeley and Lawrence Berkeley National Laboratory have discovered a new material that could capture more than 90 percent of CO2 emitted from industrial sources, such as natural gas-fired power plants, using low-temperature steam, requiring less energy for the overall carbon capture process.

Approval based on Phase III ETHOS trial which showed a statistically significant reduction in the rate of exacerbations compared with dual-combination therapies WILMINGTON, Del.--( BUSINESS WIRE )-- AstraZeneca’s BREZTRI AEROSPHERE TM (budesonide/glycopyrrolate/formoterol fumarate) has been approved in the US for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). The approval by the US Food and Drug Ad

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that it will host a conference call on Thursday, July 30, 2020 at 5pm ET to discuss second quarter 2020 financial results and provide a corporate update. The live and replayed webcast of the call will be available through the company’s we

Marrone Bio Innovations Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the second quarter ended June 30, 2020, after market close on Monday, August 10th at 4:30 pm Eastern time. The company also announced that incoming Chief Executive Officer Kevin Helash, a Canadian citizen, has received his vi

Cradle Genomics today announced the expansion of its executive team with the additions of Tanya Moreno, PhD, as Vice President of Development and Sue Gross, MD, as Chief Medical Officer.

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopt

Innovative system measures stomach motility to help clinicians identify enteral feeding intolerance Technology designed to help address malnutrition in the ICU and support clinical decision-making Baxter gains exclusive distribution rights to bring system to clinicians worldwide

CEL-SCI Corporation (NYSE American: CVM) announces that it has concluded animal experiments using its LEAPS COVID 19 conjugate that provide the basis for moving forward into animal challenge studies with live virus SARS-CoV-2, the causative agent of COVID 19, at the University of Georgia Vaccine Center. These SARS-CoV-2 challenge studies seek to repeat the success of animal challenge studies conducted previously at the NIH

Sports nutrition brand, Virtūs Nutrition, has been expanding their e-commerce model over the last six months, now with products available for purchase through online retail giant, Rakuten.com.